The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia Gabriele BrachtlJosefina Piñón HofbauerTanja Nicole Hartmann Review Article Open access 28 November 2013 Pages: 361 - 374
Low prevalence of cardiac siderosis in heavily iron loaded Egyptian thalassemia major patients Amal El BeshlawyMona El TaguiDudley J Pennell Original Article 15 August 2013 Pages: 375 - 379
Novel genetic abnormalities in Bernard-Soulier syndrome in India Shahnaz AliKanjaksha GhoshShrimati Shetty Original Article 01 September 2013 Pages: 381 - 384
Prevention, management and extent of adverse pregnancy outcomes in women with hereditary antithrombin deficiency Nina RogenhoferMichael K. BohlmannBettina Toth Original Article 03 September 2013 Pages: 385 - 392
IP-10/CXCL10 and MIG/CXCL9 as novel markers for the diagnosis of lymphoma-associated hemophagocytic syndrome Hayato MaruokaDaichi InoueTakayuki Takahashi Original Article Open access 25 August 2013 Pages: 393 - 401
Bendamustine combined with rituximab for patients with relapsed or refractory diffuse large B cell lymphoma Jeffrey L. VacircaPeter. I. AcsEric Lynam Original Article Open access 17 August 2013 Pages: 403 - 409
Physical activity and physical fitness in lymphoma patients before, during, and after chemotherapy: a prospective longitudinal study Nele VermaetePascal WolterRik Gosselink Original Article 21 August 2013 Pages: 411 - 424
Overexpressed BAG3 is a potential therapeutic target in chronic lymphocytic leukemia Huayuan ZhuWei WuJianyong Li Original Article 25 August 2013 Pages: 425 - 435
Gene expression profiles for the prediction of progression-free survival in diffuse large B cell lymphoma: results of a DASL assay Seok Jin KimInsuk SohnWon Seog Kim Original Article 24 August 2013 Pages: 437 - 447
Comparative outcomes of rituximab-based systemic therapy and splenectomy in splenic marginal zone lymphoma Adam J. OlszewskiShihab Ali Original Article 22 September 2013 Pages: 449 - 458
Lenalidomide in combination with vorinostat and dexamethasone for the treatment of relapsed/refractory peripheral T cell lymphoma (PTCL): report of a phase I/II trial Georg HopfingerThomas NösslingerRichard Greil Original Article 18 January 2014 Pages: 459 - 462
Clinical significance of the appearance of abnormal protein band in patients with multiple myeloma Jae-Cheol JoDok Hyun YoonCheolwon Suh Original Article 03 September 2013 Pages: 463 - 469
Bcl-2 expression is associated with poor prognosis of solitary plasmacytoma of bone Shanqi GuoYaqin ZhiYizhuo Zhang Original Article 08 September 2013 Pages: 471 - 477
Incidence, risk factors, and implemented prophylaxis of varicella zoster virus infection, including complicated varicella zoster virus and herpes simplex virus infections, in lenalidomide-treated multiple myeloma patients C. KönigM. KleberM. Engelhardt Original Article 07 December 2013 Pages: 479 - 484
Targeting connective tissue growth factor (CTGF) in acute lymphoblastic leukemia preclinical models: anti-CTGF monoclonal antibody attenuates leukemia growth Hongbo LuKensuke KojimaMarina Konopleva Original Article 24 October 2013 Pages: 485 - 492
Breakthrough invasive fungal diseases during echinocandin treatment in high-risk hospitalized hematologic patients Thomas S. Y. ChanHarinder GillYok-Lam Kwong Original Article 15 August 2013 Pages: 493 - 498
A mimicking “multiple liver metastasis” of breast cancer by recurrent B lymphoblastic leukemia Meiko NishimuraAtsuo OkamuraHironobu Minami Letter to the Editor 05 June 2013 Pages: 499 - 500
PET-MRI hybrid imaging in a rare case of B cell lymphoblastic lymphoma with musculoskeletal manifestation Ruth EichnerMarkus EsslerIngo Ringshausen Letter to the Editor 18 June 2013 Pages: 501 - 503
p.P2063S: a neutral VWF variant masquerading as a mutation Daniel J. HampshireAnne C. Goodeve Letter to the Editor 18 June 2013 Pages: 505 - 506
The significance of free light chain measurements in the diagnosis of myelomatous pleural effusion Ayato TsukamotoYumiko YoshikiMineo Kurokawa Letter to the Editor 25 June 2013 Pages: 507 - 508
ABCB6 RNA expression in leukemias—expression is low in acute promyelocytic leukemia and FLT3-ITD-positive acute myeloid leukemia Ajay AbrahamSreeja KarathedathPoonkuzhali Balasubramanian Letter to the Editor 22 June 2013 Pages: 509 - 512
Thrombocytopenia in very low birth weight infants Fatma Nur SariRamazan OzdemirUgur Dilmen Letter to the Editor 26 June 2013 Pages: 513 - 513
A diagnostic dilemma in AL(L)PS Cariosa Lee-BrennanMaeve O’ReillyMary Keogan Letter to the Editor 20 June 2013 Pages: 515 - 516
CD2-positive follicular lymphoma complicated by venous thrombus of surface vein Rie TabataChiharu TabataMasaru Kojima Letter to the Editor 20 June 2013 Pages: 517 - 519
IgA monoclonal gammopathy accompanying extranodal B cell lymphomas Boting WuPu ChenYunfeng Cheng Letter to the Editor 22 June 2013 Pages: 521 - 522
Mutational analysis of BCORL1 in the leukemic transformation of chronic myeloproliferative neoplasms Giada RotunnoPaola GuglielmelliAlessandro M. Vannucchi Letter to the Editor 21 June 2013 Pages: 523 - 524
Nephrolithiasis in patients exposed to deferasirox and desferioxamine: probably an age-linked event with different effects on some renal parameters Paolo RicchiMassimiliano AmmirabileLuciano Prossomariti Letter to the Editor 27 June 2013 Pages: 525 - 527
Testicular invading refractory multiple myeloma during bortezomib treatment successfully treated with lenalidomide: a case report Kotaro MiyaoReona SakemuraMasashi Sawa Letter to the Editor 03 July 2013 Pages: 529 - 530
Use of rasburicase in a pregnant woman with acute lymphoblastic leukaemia and imminent tumour lysis syndrome Jan Moritz MiddekeNormi BruckJohannes Schetelig Letter to the Editor 03 July 2013 Pages: 531 - 532
Endothelial progenitor cells and human diseases Linda SommeseMaria VascoClaudio Napoli Letter to the Editor 07 July 2013 Pages: 533 - 534
Successful allogeneic stem cell transplantation with long-term remission of ETV6/FLT3-positive myeloid/lymphoid neoplasm with eosinophilia Kazuhisa ChonabayashiMasakatsu HishizawaAkifumi Takaori-Kondo Letter to the Editor 20 July 2013 Pages: 535 - 537
Erratum to: Randomized open label phase III trial of CEOP/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin’s lymphoma (NHL). A multicenter trial by the Austrian Working Group For Medical Tumor Therapy M. A. FridrikR. GreilT. Radaszkiewicz Erratum 18 December 2013 Pages: 539 - 540
